Coloplast A/S (CLPBY) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 3 recommend buying, 3 recommend holding, and 2 recommend selling.
The analyst consensus price target for CLPBY is $14.45, representing a +113.8% upside from the current price of $6.76. Price targets range from a low of $14.45 to a high of $14.45.
